Citigroup’s Evogene EVGN Stock Holding History

Citigroup’s Portfolio EVGN Stock Details EVGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-735	Closed	-$34K	–	6195
2021 Q1	$34K	Buy	+735	New	+$45.5K	﹤0.01%	4927
2020 Q1	–	Sell	-798	Closed	-$12K	–	7653
2019 Q4	$12K	Hold	798	–	–	﹤0.01%	7136
2019 Q3	$13K	Hold	798	–	–	﹤0.01%	6944
2019 Q2	$13K	Hold	798	–	–	﹤0.01%	7225
2019 Q1	$14K	Hold	798	–	–	﹤0.01%	7114
2018 Q4	$17K	Hold	798	–	–	﹤0.01%	6943
2018 Q3	$24K	Hold	798	–	–	﹤0.01%	6994
2018 Q2	$23K	Hold	798	–	–	﹤0.01%	6845
2018 Q1	$25K	Buy	798 +323	+68%	+$12K	﹤0.01%	6620
2017 Q4	$16K	Hold	475	–	–	﹤0.01%	6829
2017 Q3	$21K	Hold	475	–	–	﹤0.01%	6423
2017 Q2	$24K	Hold	475	–	–	﹤0.01%	6190
2017 Q1	$25K	Hold	475	–	–	﹤0.01%	6120
2016 Q4	$24K	Sell	475 -318	-40%	-$18.2K	﹤0.01%	6457
2016 Q3	$50K	Buy	793 +318	+67%	+$20.9K	﹤0.01%	5654
2016 Q2	$29K	Sell	475 -2,253	-83%	-$157K	﹤0.01%	5916
2016 Q1	$182K	Buy	2,728 +2,252	+473%	+$155K	﹤0.01%	5176
2015 Q4	$38K	Hold	476	–	–	﹤0.01%	6122
2015 Q3	$39K	Hold	476	–	–	﹤0.01%	5597
2015 Q2	$42K	Hold	476	–	–	﹤0.01%	5642
2015 Q1	$42K	Sell	476 -37	-7%	-$3.45K	﹤0.01%	5631
2014 Q4	$47K	Buy	513 +37	+8%	+$3.92K	﹤0.01%	5732
2014 Q3	$61K	Sell	476 -270	-36%	-$37.3K	﹤0.01%	5154
2014 Q2	$122K	Buy	746 +270	+57%	+$46.4K	﹤0.01%	4529
2014 Q1	$91K	Sell	476 -4	-0.8%	-$758	﹤0.01%	5071
2013 Q4	$94K	Buy	+480	New	+$88.7K	﹤0.01%	5300

Other funds holding EVGN

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

PDT Partners New York $1.69B AUM 74.01% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Citigroup's EVGN Position: Q2 2021 in Review

Citigroup sold out of Evogene (EVGN) in Q2 2021, closing a stake of 735 shares — an estimated $34K sold.

Citigroup first reported a position in EVGN in Q4 2013 and held it in 26 quarters. The position peaked at $182K in Q1 2016. 42 funds tracked by Wall St. Rank hold EVGN as of Q2 2021.

Citigroup reported no remaining Evogene position as of Q2 2021 after selling out during the quarter.
Citigroup sold 735 Evogene shares in Q2 2021, an estimated $34K.
Citigroup first reported a position in Evogene in Q4 2013 and held it in 26 quarters.
Citigroup's Evogene position peaked at $182K in Q1 2016.
42 funds tracked by Wall St. Rank held Evogene as of Q2 2021.

Based on Citigroup's 13F filing for Q2 2021, filed 10 Aug 2021.